Receipt of $1.077m R&D Tax Incentive Refund

Sydney, Australia – 27 September 2021: OncoSil Medical Ltd (ASX: OSL) (OncoSil or the Company) is pleased to announce it has received a cash refund of A$1.077 million following the lodgment of the 2020/2021 financial year tax return. The cash rebate is related to the expenditure on eligible Australian and international R&D activities during the financial year. —END— Authorisation & Additional Info